Introduction
Sickle cell disease in a chronic condition and a sinister haemoglobinopathy with serious consequences and high mortality 1 .The median age survival of 14.3 yrs,with 20%deaths occurring in first 2 yrs of life,one third occurring before the fifth year of life,half between 5 and 30 yrs age and one sixth after the age of 30 2 It is caused due to substitution of glutamic acid by valine in the sixth position 3 . This results in the cell having sickle shaped cells with subsequent consequences of polymerization of RBC and finally sickle cell crises(pain,thrombosis,infection) 4, 5 .HbF is one of the types of hemoglobin seen in late foetal life 6 .Hydroxyurea is an anticancer drug which acts by neutralizing the tyrosyl free radicals and there by inhibiting the enzyme ribonucleotide reductase 7 .Electrophresis is the separation of charged particles by administration of electric current 8 .
II. Materials And Methods
Fifty patients suffering from sickle cell desease from Prince Saud Bin Jalawy Hospital were taken.HbF levels were monitored before and after administration of hydroxyurea.The HbF levels were monitored using Hb Electrophoresis.All necessary norms were taken in informing the Ethics Committee.  It is observed from the data that 48 % of beneficiary has shown increase of Hb % level 2.0-2.5 range and 4 % of them also shown increase of Hb % level of > 2.5.  It is observed that 43.33 % of benefices had shown increase in Hb % 2.0 -2.5 group followed by 6.67 % increase in > 2.5 group. 
IV. Observation And Discussion
The Mean difference in HbF was -0.3979 with SDof 0.0663 and p value ,0.0001.In males (n=30) the mean difference was -0.4087 with SD of 0.025 and p value <0.0001.I n females the mean difference was -0.3825 with SD 0.05199 and p value <0.0001.There was a previous study by Veith etal 
V. Conclusion
There is significant increase (20-25%) of HbF levels after administration of hydroxyurea in Sickle Cell Disease patients. There is significant decrease in mortality after usage of hydroxyurea in Sickle cell desease patients. There is overall improvement in well being of patients of sickle cell disease after usage of hydroxyurea. 
